📈 Jumpstart Signal Watchlist — September 04, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 Current $13.45 is 5% below 3yr high $14.14 · ⏳ SMA200 $6.59 (current price $13.45 is above) · 💰 Market Cap $759M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (6.9%)
- 🔔 Strong above EMA50 (21.9%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ Paysign (NASDAQ:PAYS) Hits New 12-Month High — MarketBeat.
🤖 Paysign shares hit a new 52-week high after the company reported Q2 earnings of $0.11 per share on revenue of $28.25 million, both above estimates. The article also highlighted raised FY2026 EPS guidance of $0.35-$0.37 and multiple bullish analyst targets.
✅ Paysign (NASDAQ:PAYS) Sets New 1-Year High — MarketBeat.
🤖 The stock reached a new 52-week high as investors reacted to the strong Q2 beat and updated FY2026 guidance. The article also noted continued buy-rated analyst coverage and higher price targets.
⚪️ Paysign (NASDAQ:PAYS) Stock Rating Lowered by Wall Street Zen — MarketBeat.
🤖 Wall Street Zen cut Paysign from strong-buy to buy, but the broader analyst view stayed positive with a consensus Buy rating and price target above the then-current share price. The downgrade is a modest negative, but it was offset by the company’s strong earnings beat and guidance raise.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: MeiraGTx Holdings plc is a clinical-stage genetic medicines company that develops gene therapies and other genetic medicine platforms for both rare and more common diseases. Its work includes programs in eye diseases, Parkinson’s disease, and radiation-induced dry mouth, along with its riboswitch technology for controlled delivery of biologic therapies.
- 🎯 Current $13.89 is 7% below 3yr high $14.97 · ⏳ SMA200 $9.69 (current price $13.89 is above) · 💰 Market Cap $1.3B
- MGTX shows decent technicals supported by positive sentiment.

💎 Quality (Q): 38/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 456% (>20%); PEG ratio 0.04 (<1.5).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 54 in healthy mid-range
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ MeiraGTx (NASDAQ:MGTX) Releases Quarterly Earnings Results, Beats Expectations By $2.17 EPS — MarketBeat.
🤖 MeiraGTx reported second-quarter EPS of $1.71, far above the analyst estimate of a $0.46 loss, and revenue also came in well ahead of expectations. The beat, along with strong pipeline and financing updates in the same reporting period, was favorable for the stock.
✅ MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Buy" Rating — MarketBeat.
🤖 Wall Street Zen upgraded MeiraGTx to Buy from Hold shortly after the company’s strong quarterly results. A higher rating is typically supportive for sentiment, especially when paired with an earnings beat and improved analyst outlook.
✅ MeiraGTx (NASDAQ:MGTX) Given New $27.00 Price Target at Royal Bank Of Canada — MarketBeat.
🤖 Royal Bank of Canada raised its price target on MeiraGTx from $26 to $27 and kept an Outperform rating. Higher targets from a major broker usually signal confidence in the company’s pipeline and can support the share price.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Quad/Graphics is a marketing experience company that provides print and related marketing services. Its offerings include printing for magazines, catalogs, direct mail, packaging, and retail inserts, along with creative, media, data, and digital marketing services.
- 🎯 Current $10.70 is 1% below 3yr high $10.85 · ⏳ SMA200 $7.40 (current price $10.70 is above) · 💰 Market Cap $510M
- QUAD shows decent technicals supported by positive sentiment.

💎 Quality (Q): 41/60
- 🏦 Base breakout (range: 6.0%); Low drawdown (14.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; PEG ratio 1.05 (<1.5).
⏰ Entry (E): 3/20
- 🔔 Strong above EMA21 (6.3%)
- 🔔 Strong above EMA50 (13.1%)
- 📈 RSI at 70 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Quad at 17th Annual Midwest IDEAS Conference: growth ... — Investing.com.
🤖 Quad said it is shifting toward higher-growth marketing, packaging, and data-driven services while continuing to reduce leverage. Management also reiterated a path toward improved profitability, which is constructive for the stock.
✅ Quad Graphics, Inc (NYSE:QUAD) Given Consensus Rating of "Buy" by Analysts — MarketBeat.
🤖 This article highlights bullish analyst sentiment, including a consensus Buy rating and a $12 average price target. It also notes Quad’s better-than-expected quarterly EPS and revenue, both supportive for shares.
✅ Quad Graphics (NYSE:QUAD) Shares Cross Above 50-Day Moving Average - Should You Sell? — MarketBeat.
🤖 The article emphasizes continued positive analyst coverage and repeated target-price increases to $13 from Benchmark and Rosenblatt. That reinforces a favorable near-term view on the stock.
🍭 Bonus (B): 0/10 — Printing & Publishing

🏢 What they do: CareDx, Inc. is a precision medicine company focused on transplant patients. It develops diagnostics, digital health tools, lab products, and patient support services to help monitor care before and after organ transplantation.
- 🎯 Current $50.88 is 3% below 3yr high $52.36 · ⏳ SMA200 $24.99 (current price $50.88 is above) · 💰 Market Cap $2.6B
- CDNA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 59/60
- 🏦 Low drawdown (14.4% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1394% (>20%); Revenue growth 52% (>15%); ROE 26% (>15%).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (6.6%)
- 🔔 Strong above EMA50 (22.1%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Jupiter Topco LLC Buys New Shares in CareDx, Inc. $CDNA — MarketBeat.
🤖 A large new institutional purchase suggests growing investor confidence in CareDx. The article also notes the company’s strong recent share performance, which is supportive for the stock.
✅ Deutsche Bank AG Purchases New Position in CareDx, Inc. $CDNA — MarketBeat.
🤖 The addition of a new institutional position is a favorable signal for CDNA. The article also highlights continued bullish analyst sentiment and prior strong quarterly results.
✅ CareDx, Inc. (NASDAQ:CDNA) Given Average Rating of "Moderate Buy" by Brokerages — MarketBeat.
🤖 This article is positive because it says brokerages rate CareDx a Moderate Buy and points to upbeat recent earnings results. The reported consensus target implies analysts still see upside in the stock.
🍭 Bonus (B): 0/10 — Medical Laboratories

🏢 What they do: ADM (Archer Daniels Midland Company) is a global agricultural processing and nutrition company that purchases crops from farmers, transports them through its logistics network, and transforms them into food, animal feed, industrial, and biofuel products.
- 🎯 Current $84.61 is 3% below 3yr high $87.32 · ⏳ SMA200 $71.80 (current price $84.61 is above) · 💰 Market Cap $41.0B
- ADM shows decent technicals supported by positive sentiment.

💎 Quality (Q): 51/60
- 🏦 Low drawdown (12.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 316% (>20%); Low LT D/E 0.32 (<1.0); PEG ratio 0.07 (<1.5).
⏰ Entry (E): 6/20
- 🔔 SMA20/SMA50 bullish crossover
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Csenge Advisory Group Purchases New Shares in Archer Daniels Midland Company $ADM — MarketBeat.
🤖 Wall Street Zen upgraded ADM from "buy" to "strong-buy," reinforcing a broadly supportive analyst tone. The article also notes ADM’s strong quarterly beat and raised 2026 EPS guidance, which are constructive for the stock.
🤖 This piece is mainly about an institutional purchase and reiterates ADM’s recent earnings beat and dividend declaration. It is mildly supportive, but the article itself is mostly ownership-flow commentary rather than a direct operating update.
🤖 Despite the headline downgrade from "strong buy" to "buy," the article still frames ADM’s outlook as generally positive, citing the earnings beat, revenue growth, and raised 2026 guidance. The stock impact is likely limited because the broader consensus remains Hold.
🤖 Zacks upgraded ADM to "strong-buy," which is favorable for sentiment. The article also highlights ADM’s earnings beat and increased 2026 EPS guidance, both of which support the stock.
🍭 Bonus (B): 0/10 — Food & Kindred Products

🏢 What they do: Magnite is an advertising technology company that provides a sell-side platform for digital advertising. Its software helps publishers and media owners manage and monetize ad inventory across channels like connected TV, video, mobile, and desktop, while also connecting them with advertisers and agencies.
- 🎯 Current $24.14 is 9% below 3yr high $26.52 · ⏳ SMA200 $15.96 (current price $24.14 is above) · 💰 Market Cap $3.5B
- MGNI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 62% (>20%); ROE 18% (>15%); Low LT D/E 0.37 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (12.1%)
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive.
✅ Magnite at Rosenblatt ai summit: ctv growth and google upside — Investing.com.
🤖 Magnite highlighted strong connected TV growth and potential upside from Google antitrust remedies. The article is positive because it reinforces the company’s growth story, though some litigation-related upside remains uncertain.
✅ Magnite, Inc. (NASDAQ:MGNI) Receives Average Rating of Moderate Buy from Brokerages — MarketBeat.
🤖 Analysts collectively maintained a Moderate Buy view with a $28.30 average target, and several firms raised targets after Magnite’s strong quarterly results. That combination is positive for the stock because it signals improved sentiment and valuation support.
⚪️ 450,000 Shares in Magnite, Inc. $MGNI Acquired by Manatuck Hill Partners LLC — MarketBeat.
🤖 This item reports a large new institutional stake in Magnite and notes broadly positive analyst sentiment. It is only mildly supportive for the stock because it is mainly a holdings update rather than a direct operational catalyst.
⚪️ Bank of New York Mellon Corp Makes New Investment in Magnite, Inc. $MGNI — MarketBeat.
🤖 The article says Bank of New York Mellon opened a new position in Magnite and reiterates that the company beat quarterly expectations. The investment filing is supportive, but the piece is mostly an ownership update rather than fresh company-specific news.
🍭 Bonus (B): 10/10 — Computer Programming & Data Processing (Technology sector)

🏢 What they do: ScanSource is a technology distributor that connects hardware, software, connectivity, and cloud solutions to channel partners and businesses. Its products and services include point-of-sale systems, barcode and data-capture equipment, networking, communications, physical security, payments, and related value-added services.
- 🎯 Current $58.48 is 1% below 3yr high $58.89 · ⏳ SMA200 $44.07 (current price $58.48 is above) · 💰 Market Cap $1.2B
- SCSC shows decent technicals supported by positive sentiment.

💎 Quality (Q): 55/60
- 🏦 Low drawdown (12.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 40% (>20%); Revenue growth 17% (>15%); Low LT D/E 0.38 (<1.0).
⏰ Entry (E): 0/20
- 📈 RSI at 61 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive.
✅ ScanSource shares jump 19% after Q4 beat and $220.5 million MicroAge deal — Yahoo Finance.
🤖 ScanSource surged after reporting stronger-than-expected quarterly results and announcing a $220.5 million acquisition of MicroAge. The earnings beat and strategic deal both point to improved growth prospects and investor confidence.
✅ ScanSource (NASDAQ:SCSC) Issues Quarterly Earnings Results — MarketBeat.
🤖 The company’s quarterly results beat estimates on both EPS and revenue, which is typically favorable for the stock. The article also notes the shares reacted positively around the report despite some analyst caution.
⚪️ Hsbc Holdings PLC Makes New Investment in ScanSource, Inc. $SCSC — MarketBeat.
🤖 This is a shareholder activity piece rather than a direct operating update. It is mildly supportive because it notes continued institutional interest, but it does not change ScanSource’s fundamentals.
🍭 Bonus (B): 0/10 — Computers & Software - Wholesale

🏢 What they do: Remitly Global, Inc. is a digital financial services provider that offers cross-border remittance and international money transfer services primarily for immigrants and their families through a mobile app and website .
- 🎯 Current $26.17 is 5% below 3yr high $27.59 · ⏳ SMA200 $18.66 (current price $26.17 is above) · 💰 Market Cap $5.5B
- RELY shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 3000% (>20%); Revenue growth 20% (>15%); ROE 27% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 55 in healthy mid-range
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (mixed coverage).
✅ Remitly (RELY) Is Up 7.2% After Strong Q2 Beat And Launch Of Global Multi-Currency Card — Yahoo Finance.
🤖 The article says Remitly posted strong second-quarter results, raised full-year revenue guidance, and launched a new multi-currency card. Those developments suggest better growth, stronger profitability, and an expanded product offering for $RELY.
✅ Remitly Global (NASDAQ:RELY) Price Target Raised to $30.00 — MarketBeat.
🤖 Cantor Fitzgerald raised its price target on Remitly and kept an overweight rating after the company’s strong earnings beat. Higher analyst targets and favorable commentary are supportive for the stock.
❌ Remitly global director Riese sells $6.3 m of stock — Investing.com.
🤖 The article reports notable insider selling by a director in early August. Large insider sales can weigh on sentiment even though they occurred after a strong earnings report.
🍭 Bonus (B): 0/10 — Business Services